Vanguard Group Inc. raised its position in Select Medical Holdings Corporation (NYSE:SEM - Free Report) by 4.7% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 13,316,069 shares of the health services provider's stock after purchasing an additional 603,079 shares during the quarter. Vanguard Group Inc. owned 10.33% of Select Medical worth $222,378,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Dimensional Fund Advisors LP raised its position in Select Medical by 1.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 4,431,469 shares of the health services provider's stock valued at $83,533,000 after purchasing an additional 62,585 shares during the period. Principal Financial Group Inc. raised its position in Select Medical by 3.1% in the first quarter. Principal Financial Group Inc. now owns 2,476,816 shares of the health services provider's stock valued at $41,363,000 after purchasing an additional 73,308 shares during the period. Hood River Capital Management LLC raised its position in Select Medical by 404.8% in the fourth quarter. Hood River Capital Management LLC now owns 1,755,733 shares of the health services provider's stock valued at $33,096,000 after purchasing an additional 1,407,902 shares during the period. The Manufacturers Life Insurance Company increased its position in shares of Select Medical by 2,552.7% during the fourth quarter. The Manufacturers Life Insurance Company now owns 1,596,414 shares of the health services provider's stock worth $30,092,000 after acquiring an additional 1,536,234 shares during the period. Finally, Northern Trust Corp increased its position in shares of Select Medical by 12.9% during the fourth quarter. Northern Trust Corp now owns 1,352,046 shares of the health services provider's stock worth $25,486,000 after acquiring an additional 153,992 shares during the period. Hedge funds and other institutional investors own 89.48% of the company's stock.
Select Medical Stock Up 3.2%
Shares of SEM stock traded up $0.4150 on Friday, reaching $13.4050. 985,317 shares of the stock were exchanged, compared to its average volume of 1,267,498. The company has a current ratio of 1.15, a quick ratio of 1.15 and a debt-to-equity ratio of 0.92. The business's 50 day moving average price is $14.04 and its 200 day moving average price is $15.71. The company has a market capitalization of $1.66 billion, a price-to-earnings ratio of 12.65, a PEG ratio of 0.71 and a beta of 1.25. Select Medical Holdings Corporation has a twelve month low of $11.65 and a twelve month high of $40.98.
Select Medical (NYSE:SEM - Get Free Report) last issued its earnings results on Thursday, July 31st. The health services provider reported $0.32 EPS for the quarter, topping analysts' consensus estimates of $0.28 by $0.04. The firm had revenue of $1.34 billion during the quarter, compared to the consensus estimate of $1.35 billion. Select Medical had a net margin of 2.37% and a return on equity of 8.87%. The company's revenue was up 4.5% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.60 earnings per share. Select Medical has set its FY 2025 guidance at 1.090-1.19 EPS. As a group, sell-side analysts expect that Select Medical Holdings Corporation will post 1.17 earnings per share for the current fiscal year.
Select Medical Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Thursday, August 28th. Investors of record on Wednesday, August 13th will be paid a dividend of $0.0625 per share. The ex-dividend date is Wednesday, August 13th. This represents a $0.25 dividend on an annualized basis and a dividend yield of 1.9%. Select Medical's payout ratio is presently 23.58%.
Select Medical declared that its Board of Directors has approved a share repurchase program on Thursday, May 1st that permits the company to buyback $1.00 billion in shares. This buyback authorization permits the health services provider to buy up to 42.6% of its stock through open market purchases. Stock buyback programs are usually an indication that the company's management believes its stock is undervalued.
Analysts Set New Price Targets
SEM has been the topic of a number of recent research reports. Royal Bank Of Canada cut their price objective on Select Medical from $23.00 to $19.00 and set an "outperform" rating on the stock in a research report on Wednesday, May 7th. UBS Group reaffirmed a "neutral" rating and set a $14.00 price objective (down previously from $15.00) on shares of Select Medical in a research report on Monday, August 4th. Three equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $20.25.
Check Out Our Latest Report on SEM
Select Medical Company Profile
(
Free Report)
Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.
Featured Articles

Before you consider Select Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Select Medical wasn't on the list.
While Select Medical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.